Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

NCT06092957 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

504

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
De-escalation Therapy

Interventions

DRUG: Cisplatin-based induction chemotherapy
DRUG: Full course of PD-1/PD-L1 blockades
RADIATION: Reduced-dose IMRT
RADIATION: Standard-dose IMRT
DRUG: Concurrent Chemotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]